FDA Approved: XENPOZYME — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

FDA approved a supplemental application for XENPOZYME (olipudase alfa-RPCP) from Genzyme Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acid Sphingomyelinase Deficiency
• Niemann-pick Disease Type

Drugs mentioned

• XENPOZYME (olipudase alfa-RPCP)

Snippet

SUPPL AP for XENPOZYME (OLIPUDASE ALFA-RPCP)